CHURCH KATRINA J 4
4 · Bioventus Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Bioventus (BVS) SVP Katrina Church Exercises Options
What Happened
Katrina J. Church, SVP & Chief Compliance Officer of Bioventus (BVS), exercised/converted derivatives on March 13, 2026 and reported multiple prior and new RSU/option grants. On 2026-03-13 she converted/exercised 3,455 and 3,500 derivative units (reported at $0.00 exercise price), and to satisfy tax withholding she surrendered 1,501 and 1,521 shares at $8.62 each (total withholding ≈ $26,050). The filing also reports grants/awards of RSUs/options: 14,000 and 16,000 (granted 2025-03-14), 24,000 and 27,000 (granted 2026-03-13), plus an original 13,823-RSU grant noted in a footnote.
Key Details
- Transaction dates: March 14, 2025 (grants) and March 13, 2026 (exercises/conversions, grants, and tax withholding). Filing date: 2026-03-17 (Accession 0001204391-26-000004).
- Tax withholding sales: 1,501 shares × $8.62 = $12,939; 1,521 shares × $8.62 = $13,111; combined ≈ $26,050.
- Exercises/conversions (reported at $0.00): 3,455 and 3,500 shares on 2026-03-13 (acquired as part of derivative conversion).
- Grants/awards reported: 14,000 and 16,000 (3/14/2025); 24,000 and 27,000 (3/13/2026); original 13,823 RSUs (earlier grant).
- Footnotes: F1—each RSU converts to one share on settlement; F2/F3—new RSUs/options vest in four equal annual installments starting March 15, 2025 and March 15, 2026 respectively; F4—original 13,823 RSUs vest began March 14, 2023.
- Shares owned after the transactions are not specified in the provided excerpt. No explicit late-filing indicator was provided in the supplied data.
Context
- This appears to be routine equity compensation activity: RSU/option grants and conversion/exercise of derivatives with shares withheld/surrendered to cover tax obligations (code F), effectively a cashless tax-withholding mechanism. Such withholding is common and does not necessarily indicate a deliberate market sale for investment reasons.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
2026-03-13+3,455→ 61,254 total - Tax Payment
Class A Common Stock
2026-03-13$8.62/sh−1,501$12,939→ 59,753 total - Exercise/Conversion
Class A Common Stock
2026-03-13+3,500→ 63,253 total - Tax Payment
Class A Common Stock
2026-03-13$8.62/sh−1,521$13,111→ 61,732 total - Award
Restricted Stock Units
[F1][F2]2025-03-14+14,000→ 14,000 total→ Class A Common Stock (14,000 underlying) - Award
Stock Option (Right to Buy)
[F2]2025-03-14+16,000→ 16,000 totalExercise: $9.61Exp: 2035-03-14→ Class A Common Stock (16,000 underlying) - Award
Restricted Stock Units
[F1][F3]2026-03-13+24,000→ 24,000 total→ Class A Common Stock (24,000 underlying) - Award
Stock Option (Right to Buy)
[F3]2026-03-13+27,000→ 27,000 totalExercise: $8.62Exp: 2036-03-13→ Class A Common Stock (27,000 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-03-13−3,455→ 0 total→ Class A Common Stock (3,455 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-03-13−3,500→ 10,500 total→ Class A Common Stock (3,500 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- [F2]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
- [F3]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
- [F4]The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023.